Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 24, 2025
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
GlobeNewswire
·
April 24, 2025
Norovirus GII.17 variants have overtaken GII.4 as the most prevalent strain and significantly increased norovirus outbreaks in the U.S. and European countries in 2024-2025 Cocrystal Pharma’s pan-viral protease inhibitor CDI-988 shows superior broad- …
Prebid.org Debuts New Analytics Dashboard, Prebid Insights
GlobeNewswire
·
April 24, 2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Prebid.org, the organization that oversees open source Prebid programmatic advertising solutions, today announced the launch of Prebid Insights, a new, publicly available analytics dashboard designed to provide …
Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Technologies
GlobeNewswire
·
April 24, 2025
Presentations will be delivered by experts from a wide variety of leading research groups including Pfizer, GSK, and Bio-Techne, along with co-hosts IPA, ACROBiosystems, and Curia. SALT LAKE CITY, April 24, 2025 (GLOBE NEWSWIRE) -- Carterra Inc., the world …
Performance Unlocked: AdOmni and LiveRamp Bring New Targeting and Attribution to CTV, OLV, and DOOH
GlobeNewswire
·
April 24, 2025
LAS VEGAS and SAN FRANCISCO, April 24, 2025 (GLOBE NEWSWIRE) -- Marketers have long struggled to measure the business impact of CTV, OLV, and DOOH—keeping these high-reach channels siloed from performance strategies. Today, AdOmni, the AI-powered video- …
Global Uranium and Forum Energy Metals Announce the Completion of Drilling and Ground Geophysical Surveys on the Northwest Athabasca Project, Saskatchewan
GlobeNewswire
·
April 24, 2025
CALGARY, Alberta, April 24, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the "Company" or “Global”) and Forum Energy Metals Corp. (TSX.V: FMC; OTCQB: FDCFF) (“Forum”) are pleased to announce that it has completed its …
NevGold Discovers More Significant Oxide Gold-Antimony Results: 2.11 g/t AuEq Over 67.1 Meters (1.30 g/t Au And 0.18% Antimony), Including 4.29 g/t AuEq Over 30.5 Meters (2.79 g/t Au And 0.33% Antimony), and Also Including 7.12 g/t AuEq Over 16.8…
GlobeNewswire
·
April 24, 2025
Vancouver, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant oxide gold-antimony (“Antimony”, “Sb”) …
Krystal Biotech to Present at Upcoming Scientific Conferences
GlobeNewswire
·
April 24, 2025
PITTSBURGH, April 24, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the Company will be presenting on multiple programs in the lung, eye, and skin at upcoming scientific conferences being held in May and …
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
GlobeNewswire
·
April 24, 2025
CAMBRIDGE, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
Reviva to Present Late-Breaking Poster on the RECOVER Long-term Open Label Extension Trial for Brilaroxazine in Schizophrenia at the 2025 ASCP Annual Meeting
GlobeNewswire
·
April 24, 2025
CUPERTINO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of …
X4 Pharmaceuticals Announces Reverse Stock Split
GlobeNewswire
·
April 24, 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its board of directors has determined to effect a one-for-thirty …
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
GlobeNewswire
·
April 24, 2025
MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Enable Medicine, a real-world data company providing AI-ready patient, cellular and molecular data, today announced a …
Snyk Achieves FedRAMP Moderate Authorization
GlobeNewswire
·
April 24, 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Snyk, a leader in developer security, today announced it has achieved FedRAMP Moderate Authorization, completing the FedRAMP process for Snyk for Government. This achievement underscores Snyk’s commitment to …
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
GlobeNewswire
·
April 24, 2025
MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, today announced the availability of a new assay designed to advance antibody-drug conjugate (ADC) development in breast cancer. The …
Fourth Annual RetailTech Breakthrough Awards Program Honors World’s Most Innovative Retail Technology Companies
GlobeNewswire
·
April 24, 2025
LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RetailTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout retail technology companies, products and services around the globe, today announced the …
ORYZON Raises €30 Million in Capital Increase
GlobeNewswire
·
April 24, 2025
Issued 12,765,958 new shares Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP Strong investor demand, with the offering significantly oversubscribed €15 million anchored by a leading US institutional investor Proceeds to fund …
ZenaTech’s ZenaDrone Granted FAA Part 137 Approval for Agricultural Drone Operations Addressing a $6 Billion Global Agricultural Drone Market Growing to $24 Billion by 2032
GlobeNewswire
·
April 24, 2025
VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and …
Applied Materials to Report Fiscal Second Quarter 2025 Results on May 15, 2025
GlobeNewswire
·
April 24, 2025
SANTA CLARA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that it will hold its fiscal second quarter 2025 earnings conference call on Thursday, May 15, 2025, at 4:30 p.m. ET / 1:30 p.m. PT. The call will be webcast …
Ace Vision Group Announces Initial Close of $29.4 Million Series B Financing Round
GlobeNewswire
·
April 24, 2025
Funding supports the commercial product development of VisioLite® Device and Laser Scleral Microporation Human Clinical Study. Capital raised to date provides strong financial position to prepare the device for regulatory trials and submissions. BOSTON, …
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
GlobeNewswire
·
April 24, 2025
- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for late 2025 - WALTHAM, Mass., April 24, 2025 (GLOBE …
Plato Gold Reports on 2024 Year-End Results
GlobeNewswire
·
April 24, 2025
Toronto,, April 24, 2025 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) an exploration company with a portfolio of properties in Northern Ontario and Santa Cruz, Argentina is …